The increasing interest in peptides has led a large grey sector, presenting grave risks to individuals. Such materials are often manufactured outside strict regulatory oversight, meaning the quality and strength can be very inconsistent. Moreover, the suppliers may omit correct data regarding components, potential side effects, and suitable adminis